These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells. Van YH, Lee WH, Ortiz S, Lee MH, Qin HJ, Liu CP. Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738 [Abstract] [Full Text] [Related]
6. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes. Zhang Y, Lee AS, Shameli A, Geng X, Finegood D, Santamaria P, Dutz JP. J Immunol; 2010 May 15; 184(10):5645-53. PubMed ID: 20393135 [Abstract] [Full Text] [Related]
7. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells. Augstein P, Dunger A, Heinke P, Wachlin G, Berg S, Hehmke B, Salzsieder E. Biochem Biophys Res Commun; 2003 May 02; 304(2):378-84. PubMed ID: 12711326 [Abstract] [Full Text] [Related]
10. Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development. Mori Y, Kodaka T, Kato T, Kanagawa EM, Kanagawa O. Int Immunol; 2009 Nov 02; 21(11):1291-9. PubMed ID: 19778991 [Abstract] [Full Text] [Related]
11. Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice. Yeh LT, Miaw SC, Lin MH, Chou FC, Shieh SJ, Chuang YP, Lin SH, Chang DM, Sytwu HK. J Immunol; 2013 Jul 15; 191(2):594-607. PubMed ID: 23752610 [Abstract] [Full Text] [Related]
12. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice. Han HS, Jun HS, Utsugi T, Yoon JW. J Autoimmun; 1997 Jun 15; 10(3):299-307. PubMed ID: 9218758 [Abstract] [Full Text] [Related]
14. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes. Ogawa N, Minamimura K, Kodaka T, Maki T. J Autoimmun; 2006 Jun 15; 26(4):225-31. PubMed ID: 16713179 [Abstract] [Full Text] [Related]
15. Prevention of autoimmune type I diabetes by CD4+ suppressor T cells in superantigen-treated non-obese diabetic mice. Kawamura T, Nagata M, Utsugi T, Yoon JW. J Immunol; 1993 Oct 15; 151(8):4362-70. PubMed ID: 8409408 [Abstract] [Full Text] [Related]
16. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. Han HS, Jun HS, Utsugi T, Yoon JW. J Autoimmun; 1996 Jun 15; 9(3):331-9. PubMed ID: 8816968 [Abstract] [Full Text] [Related]
18. MicroRNA-26a Promotes Regulatory T cells and Suppresses Autoimmune Diabetes in Mice. Ma H, Zhang S, Shi D, Mao Y, Cui J. Inflammation; 2016 Feb 15; 39(1):1-9. PubMed ID: 26208605 [Abstract] [Full Text] [Related]
20. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells. Reddy S, Karanam M, Krissansen G, Nitschke K, Neve J, Poole CA, Ross JM. Histochem J; 2000 Apr 15; 32(4):195-206. PubMed ID: 10872884 [Abstract] [Full Text] [Related] Page: [Next] [New Search]